Mesoblast (ASX:MSB) - Webinar Presentation ********* 4.3K subscribers
4 views 8 Mar 2024Silviu Itescu - CEO - Mesoblast (ASX:MSB) is using its proprietary mesenchymal lineage cell technology platform to develop and commercialise innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care.
Mesoblast (ASX:MSB) - Webinar Presentation ********* 4.3K...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.090B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 94.0¢ | $552.4K | 580.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 71618 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 55899 | 52 |
View Market Depth
| Last trade - 12.05pm 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |